can tirzepatide cause bone loss GLP-1 Drugs and of Density: Exercise Reduce Your Risk I kept seeing patients on

The specific biomarkers focused on were adiponectin, leptin, IL-6, TNF-, plasminogen activator inhibitor-1 (PAI-1), brain natriuretic peptide (BNP), and high-sensitivity C-reactive protein (hs-CRP)

GLP-1 RAs exert their therapeutic effects through multiple mechanisms, primarily by stimulating the GLP-1 receptor, which in turn enhances insulin secretion, suppresses glucagon release, delays gastric emptying, and promotes satiety

Uses: Dosage and Administration: The recommended dosage is 12.5 mg once weekly subcutaneously (abdomen, thigh, or upper arm, rotating sites)

Current research shows a possible association rather than confirmed causation, as patients taking semaglutide often have underlying risk factors including obesity and metabolic syndrome